Interstitial lung disease appears to be a risk factor for radiation pneumonitis, a potentially life-threatening adverse effect of radiotherapy to the chest and thorax.
[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.
Radiogenomics is maturing into a predictor of patients' likelihood of experiencing radiotoxicities and late radiation effects.
Psychosocial decline occurs in an estimated one-third of patients undergoing radiotherapy for cancer. These declines may sometimes be ameliorated by vigilant recognition of the need to refer patients for psychosocial support interventions.
High-dose-rate (HDR) brachytherapy is typically used as a dose-escalating boost for external beam radiotherapy for prostate cancer; however, some researchers believe it might be close to graduating to a viable monotherapy.
Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.
What is the best approach to learning more about the field of Radiation Oncology?
Is there a difference in dosing (1 hour prior to radiotherapy vs bedtime) with temozolomide plus radiotherapy for glioblastoma multiforme?
Is combination therapy of imatinib (Gleevec) and radiotherapy safe?
Sexual dysfunction is a common and distressing side effect of prostate cancer treatment. Two new reports from randomized clinical trials offer mixed results for adjuvant pharmacotherapy intended to prevent erectile dysfunction in men undergoing radiotherapy for prostate cancer.
New evidence indicates that combining chemotherapy with radiation therapy may be the best option for people with a low-grade form of brain cancer.
Patients with cancer desire more information from health care professionals about medical imaging tests that use radiation.
Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.
The use of 3D printing to construct devices of varied sizes and shapes could become a powerful tool in customizing interventional radiology treatments to individual patient needs.
A recent study has determined that radiation therapy is the most common treatment for prostate cancer regardless of cancer stage, PSA level, or prognosis and risk rating.
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.
More than a third of women who should receive radiation subsequent to mastectomy are actually undergoing the recommended postmastectomy radiation therapy (PMRT), according to a new study.
A new study has identified three genes that combined enable a lethal form of brain cancer to recur and progress after radiation therapy.
A novel radio-guided surgery technique could quickly and effectively identify residual cancer cells during brain tumor surgery, reducing radiation exposure for both patients and surgeons.
Radiotherapy can be avoided by older women with breast cancer without a compromise to their safety, according to a recent study.
- Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
- Childhood leukemia study reveals disease subtypes and new treatment options
- Counseling cancer patients on effective nutritional practices
- Radiation plus immunotherapy revs up immune system to better attack melanoma
- Chemotherapy before breast cancer surgery increases likelihood of breast-preserving procedure
- Scent-trained dog detects thyroid cancer in human urine samples
- Report shows U.S. cancer deaths on the decline
- Leafy green vegetables may slow mental deterioration
- Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
- Risk of breast cancer in transgender persons studied in veterans
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|